Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Ophthalmologic Medicine(Electronic Edition) ›› 2020, Vol. 10 ›› Issue (01): 1-5. doi: 10.3877/cma.j.issn.2095-2007.2020.01.001

• Editorial •     Next Articles

Pay attention to the problems in diagnosis and treatments of adenoid cystic carcinoma of lacrimal gland

Jianmin Ma1,(), Rui Liu2   

  1. 1. Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing 100730, China
    2. Master′s degree 2018, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
  • Received:2019-10-18 Online:2020-02-28 Published:2021-11-12
  • Contact: Jianmin Ma

Abstract:

Adenoid cystic carcinoma (ACC) is the most common malignant neoplasm in lacrimal gland, with a high recurrence rate and mortality. The pathogenesis of this disease is unknown and the prognosis is poor. At present, there is no standardized diagnosis and treatment plan for adenoid cystic carcinoma of ACC in lacrimal gland, and there are some problems in clinical diagnosis and treatment. In order to improve the quality of diagnosis and treatment of ACC in lacrimal gland, the issues needing attention from the aspects of epidemiology, clinical manifestations, choice of imaging examination, diagnosis and differential diagnosis, pathological changes and immunohistochemical indicators, choice of treatment options, and prognostic factors were discussed, which is of great benifit to strengthen clinicians′ attention to these issues, improve the ability to deal with the disease in the early stage, and decrease the misdiagnosis rate.

Key words: Lacrimal gland, Adenoid cystic carcinoma, Diagnosis, Treatment, Prognosis

Copyright © Chinese Journal of Ophthalmologic Medicine(Electronic Edition), All Rights Reserved.
Tel: 0086-10-58269646 E-mail: zhykyxzz@163.com
Powered by Beijing Magtech Co. Ltd